1. Home/
  2. Compounds/
  3. erlotinib:PLX-4032 (2:1 mol/mol)

erlotinib:PLX-4032 (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2erlotinib:PLX-4032 (2:1 mol/mol)
PharmacoGx erlotinib:PLX-4032 (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to erlotinib:PLX-4032 (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA PRPF38A CTRPv2 pan-cancer AAC -0.1 0.02
mRNA PIGB CTRPv2 pan-cancer AAC 0.094 0.02
mRNA UBE2QL1 CTRPv2 pan-cancer AAC -0.089 0.02
mRNA SARNP CTRPv2 pan-cancer AAC -0.097 0.02
mRNA HIPK1 CTRPv2 pan-cancer AAC -0.092 0.02
mRNA SERPINB2 CTRPv2 pan-cancer AAC 0.092 0.02
mRNA PDE6C CTRPv2 pan-cancer AAC -0.094 0.02
mRNA DEFB126 CTRPv2 pan-cancer AAC 0.089 0.02
mRNA CBR3 CTRPv2 pan-cancer AAC 0.1 0.02
mRNA CCDC74B CTRPv2 pan-cancer AAC -0.092 0.02
Download CSV